AACR 2025 Round-Up
Certis' lead developer presented CertisOI Assistant™, an exciting new agentic AI tool that optimizes preclinical model selection and brings greater certainty to early decision-making.
VIEW OUR POSTER
What We Do
Certis Oncology Intelligence® combines powerful predictive AI with advanced preclinical models to deliver clear and compelling evidence of therapeutic efficacy.
The Certis Way
Innovation, collaboration, and the relentless pursuit of precision.
Company News
Certis Announces Issuance of U.S. Patent for CertisAI™
“By offering CertisAI as a service, we are democratizing access to powerful AI/ML tools,"
Awards & Recognition
Certis Receives Scientist.com’s Supplier Recognition Award
Certis was recognized for outstanding performance in drug discovery research services.
Unite.AI Interview
Harnessing AI for Oncology: Insights from Certis CEO Peter Ellman
Over 90% of oncology drugs fail in clinical trials. What if preclinical insights could change that?